A good antisense molecule is hard to find

被引:146
作者
Branch, AD [1 ]
机构
[1] Mt Sinai Sch Med, Dept Med, Div Liver Dis, New York, NY 10029 USA
关键词
D O I
10.1016/S0968-0004(97)01155-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antisense molecules and ribozymes capture the imagination with their promise of rational drug design and exquisite specificity. However, they are far more difficult to produce than was originally anticipated, and their ability to eliminate the function of a single gene has never been proven. Furthermore, a wide variety of unexpected non-antisense effects have come to light. Although some of these side effects will almost certainly have clinical value, they make it hard to produce drugs that act primarily through true antisense mechanisms and complicate the use of antisense compounds as research reagents. To minimize unwanted non-antisense effects, investigators are searching for antisense compounds and ribozymes whose target sites are particularly vulnerable to attack, This is a challenging quest.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 45 条
[11]   Progress in antisense oligonucleotide therapeutic [J].
Crooke, ST ;
Bennett, CF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :107-129
[12]   Proof of mechanism of antisense drugs [J].
Crooke, ST .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1996, 6 (02) :145-147
[13]   Natural antisense RNA target RNA interactions: Possible models for antisense oligonucleotide drug design [J].
Delihas, N ;
Rokita, SE ;
Zheng, P .
NATURE BIOTECHNOLOGY, 1997, 15 (08) :751-753
[14]   SINGLE-BASE DISCRIMINATION FOR RIBONUCLEASE H-DEPENDENT ANTISENSE EFFECTS WITHIN INTACT HUMAN LEUKEMIA-CELLS [J].
GILES, RV ;
RUDDELL, CJ ;
SPILLER, DG ;
GREEN, JA ;
TIDD, DM .
NUCLEIC ACIDS RESEARCH, 1995, 23 (06) :954-961
[15]   ANTISENSE HAS GROWING PAINS [J].
GURA, T .
SCIENCE, 1995, 270 (5236) :575-577
[16]   SIMPLE RNA ENZYMES WITH NEW AND HIGHLY SPECIFIC ENDORIBONUCLEASE ACTIVITIES [J].
HASELOFF, J ;
GERLACH, WL .
NATURE, 1988, 334 (6183) :585-591
[17]  
HELENE C, 1991, ANTI-CANCER DRUG DES, V6, P569
[19]   Specificity of hammerhead ribozyme cleavage [J].
Hertel, KJ ;
Herschlag, D ;
Uhlenbeck, OC .
EMBO JOURNAL, 1996, 15 (14) :3751-3757
[20]  
HOLLENBERG MD, 1995, PRINCIPLES PHARM BAS, P7